Current research on COL3A1 focuses on understanding its role in various diseases, developing therapies for conditions associated with COL3A1 mutations, and exploring its potential in tissue engineering. Advances in genomic editing technologies, such as CRISPR/Cas9, hold promise for correcting COL3A1 mutations in affected individuals. Additionally, studies are investigating the use of COL3A1 in creating artificial tissues and scaffolds for regenerative medicine.
